Thrombosis in Cancer: Research Priorities Identified by a National Cancer Institute/National Heart, Lung, and Blood Institute Strategic Working Group

被引:25
作者
Key, Nigel S. [1 ]
Khorana, Alok A. [2 ]
Mackman, Nigel [1 ]
McCarty, Owen J. T. [3 ]
White, Gilbert C. [4 ]
Francis, Charles W. [5 ,6 ]
McCrae, Keith R. [2 ,7 ]
Palumbo, Joseph S. [8 ]
Raskob, Gary E. [9 ]
Chan, Andrew T. [10 ,11 ]
Sood, Anil K. [12 ,13 ]
机构
[1] Univ North Carolina Chapel Hill, Div Hematol Oncol, Chapel Hill, NC 27599 USA
[2] Cleveland Clin, Taussig Canc Inst, Dept Hematol & Oncol, Cleveland, OH USA
[3] Oregon Hlth & Sci Univ, Dept Biomed Engn & Cell & Dev Biol, Portland, OR USA
[4] Med Coll Wisconsin, Blood Res Inst, Blood Ctr Wisconsin, Dept Med Biochem & Pharmacol, Milwaukee, WI 53226 USA
[5] Univ Rochester, James P Wilmot Canc Ctr, Rochester, NY USA
[6] Univ Rochester, Dept Med, Rochester, NY USA
[7] Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH 44106 USA
[8] Cincinnati Childrens Hosp Med Ctr, Div Hematol, Cincinnati, OH 45229 USA
[9] Univ Oklahoma, Hlth Sci Ctr, Coll Publ Hlth, Dept Biostat & Epidemiol, Oklahoma City, OK USA
[10] Massachusetts Gen Hosp, Dept Med, Clin & Translat Epidemiol Unit, Boston, MA 02114 USA
[11] Massachusetts Gen Hosp, Dept Med, Div Gastroenterol, Boston, MA 02114 USA
[12] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA
[13] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA
关键词
VENOUS THROMBOEMBOLISM; TISSUE FACTOR; ORAL RIVAROXABAN; TUMOR-CELLS; MICROPARTICLES; THROMBOPROPHYLAXIS; PROPHYLAXIS; WARFARIN; SURGERY; DNA;
D O I
10.1158/0008-5472.CAN-15-3100
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The risk for venous thromboembolism (VTE) is increased in cancer and particularly with chemotherapy, and it portends poorer survival among patients with cancer. However, many fundamental questions about cancer-associated VTE, or Trousseau syndrome, remain unanswered. This report summarizes the proceedings of a working group assembled by the NCI and NHLBI in August 2014 to explore the state of the science in cancer-associated VTE, identify clinically important research gaps, and develop consensus on priorities for future research. Representing a convergence of research priorities between the two NIH Institutes, the workshop addressed epidemiologic, basic science, clinical, and translational issues in cancer-associated VTE. (C) 2016 AACR.
引用
收藏
页码:3671 / 3675
页数:5
相关论文
共 36 条
[1]   A clinical outcome-based prospective study on venous thromboembolism after cancer surgery -: The @RISTOS project [J].
Agnelli, G ;
Bolis, G ;
Capussotti, L ;
Scarpa, RM ;
Tonelli, F ;
Bonizzoni, E ;
Moia, M ;
Parazzini, F ;
Rossi, R ;
Sonaglia, F ;
Valarani, B ;
Bianchini, C ;
Gussoni, G ;
Andreoni, B ;
Biffi, R ;
Cenciarelli, S ;
Capussotti, L ;
Calgaro, M ;
Polastri, R ;
Zorzi, D ;
Mazzini, G ;
Tubaro, A ;
Perna, R ;
Vicentini, C ;
Montemurro, S ;
Caliandro, C ;
Ruggeri, E ;
Gennari, L ;
Brocchi, A ;
Quagliuolo, V ;
Scarpa, RM ;
Ragni, F ;
Conti, G ;
Cretarola, E ;
Pagliarulo, A ;
D'Achille, G ;
Bartoli, A ;
Bussotti, C ;
Ricci, E ;
Servoli, A ;
Carrieri, G ;
Corvasce, T ;
Disabato, G ;
Moretti, R ;
Bencini, L ;
Cantafio, S ;
Scatizzi, M ;
Scambia, G ;
Foti, E ;
Frigerio, L .
ANNALS OF SURGERY, 2006, 243 (01) :89-95
[2]   High D-dimer levels are associated with poor prognosis in cancer patients [J].
Ay, Cihan ;
Dunkler, Daniela ;
Pirker, Robert ;
Thaler, Johannes ;
Quehenberger, Peter ;
Wagner, Oswald ;
Zielinski, Christoph ;
Pabinger, Ingrid .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (08) :1158-1164
[3]   Prediction of venous thromboembolism in cancer patients [J].
Ay, Cihan ;
Dunkler, Daniela ;
Marosi, Christine ;
Chiriac, Alexandru-Laurentiu ;
Vormittag, Rainer ;
Simanek, Ralph ;
Quehenberger, Peter ;
Zielinski, Christoph ;
Pabinger, Ingrid .
BLOOD, 2010, 116 (24) :5377-5382
[4]   Oral Rivaroxaban for Symptomatic Venous Thromboembolism. [J].
Bauersachs, Rupert ;
Berkowitz, Scott D. ;
Brenner, Benjamin ;
Buller, Harry R. ;
Decousus, Herve ;
Gallus, Alex S. ;
Lensing, Anthonie W. ;
Misselwitz, Frank ;
Prins, Martin H. ;
Raskob, Gary E. ;
Segers, Annelise ;
Verhamme, Peter ;
Wells, Phil ;
Agnelli, Giancarlo ;
Bounameaux, Henri ;
Cohen, Alexander ;
Davidson, Bruce L. ;
Piovella, Franco ;
Schellong, Sebastian .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (26) :2499-2510
[5]  
Bergqvist D, 1997, BRIT J SURG, V84, P1099
[6]   Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. [J].
Bergqvist, D ;
Agnelli, G ;
Cohen, AT ;
Eldor, A ;
Nilsson, PE ;
Le Moigne-Amrani, A ;
Dietrich-Neto, F .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (13) :975-980
[7]   The role of platelet activation in tumor metastasis [J].
Borsig, Lubor .
EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (08) :1247-1255
[8]   Neutrophil extracellular traps kill bacteria [J].
Brinkmann, V ;
Reichard, U ;
Goosmann, C ;
Fauler, B ;
Uhlemann, Y ;
Weiss, DS ;
Weinrauch, Y ;
Zychlinsky, A .
SCIENCE, 2004, 303 (5663) :1532-1535
[9]   Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism [J].
Buller, Harry R. ;
Prins, Martin H. ;
Lensing, Anthonie W. A. ;
Decousus, Herve ;
Jacobson, Barry F. ;
Minar, Erich ;
Chlumsky, Jaromir ;
Verhamme, Peter ;
Wells, Phil ;
Agnelli, Giancarlo ;
Cohen, Alexander ;
Berkowitz, Scott D. ;
Bounameaux, Henri ;
Davidson, Bruce L. ;
Misselwitz, Frank ;
Gallus, Alex S. ;
Raskob, Gary E. ;
Schellong, Sebastian ;
Segers, Annelise .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (14) :1287-1297
[10]   Rates of venous thromboembolism in multiple myeloma patients undergoing immunomodulatory therapy with thalidomide or lenalidomide: a systematic review and meta-analysis [J].
Carrier, M. ;
Le Gal, G. ;
Tay, J. ;
Wu, C. ;
Lee, A. Y. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (04) :653-663